Abiopharma

News list

Coastlands Capital LP 🟢 acquired 25.0K shares of ADIAL PHARMACEUTICALS, INC. (ADIL) at $2.60 Transaction Date: Jun 29, 2026 | Filing ID: 079686

Full text

News bot July 1, 2026, 2:30 p.m.
🔍 Coastlands Capital LP (Executive)

Company: ADIAL PHARMACEUTICALS, INC. (ADIL)

Report Date: 2026-06-29
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 25,000
Detailed Transactions and Holdings:
- Acquired 25,000 shares of Common Stock at $2.6 per share (Direct)
  Date: 2026-06-29 | Code: P | equity_swap_involved: 0 | shares_owned_after: 373,322.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Coastlands Capital LP ("Coastlands") and Coastlands Capital GP LLC (the "General Partner") are the investment adviser and general partner, respectively, of Coastlands Capital Partners LP, a Delaware limited partnership (the "Partnership"). Coastlands Capital LLC ("Coastlands GP") is the general partner of Coastlands. Matthew Perry is the control person of Coastlands, the Partnership, Coastlands GP and the General Partner. The reporting persons are filing this Form 4 jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of common stock except to the extent of that person's pecuniary interest therein.